OBJECTIVES To test, using a mouse renal cancer, Renca, whether adoptive transfer of tumor-reactive transforming growth factor (TOF)-beta-insensitive cytolytic T cells can inhibit tumor progression. METHODS Cytolytic T cells were isolated from the spleen of male Balb/c mice repeatedly primed with irradiated Renca cells. They were expanded ex vivo and were rendered TGF-beta-insensitive by infecting with a retrovirus containing dominant negative TGF-beta type II receptor. RESULTS These tumor reactive TGF-beta-insensitive cytolytic T cells showed a specific and robust tumor killing activity against Renca cells, but not irrelevant cells, using an in vitro cytotoxic assay. Adoptive transfer of cytolytic T cells was performed in mice 10 days...
Adoptive T-cell therapy is a cancer treatment strategy where T cells from a cancer patient are harve...
With the establishment of clinically effective adoptive T-cell therapy for metastatic cancer, effort...
Activated T cells expressing endogenous or transduced TCRs are two cell types currently used in clin...
Transforming growth factor beta (TGF-beta) is a potent immunosuppressant. The present study was cond...
Purpose: Transforming growth factor-beta (TGF-beta) is a potent immunosuppressor that has been assoc...
In order to test the effectiveness of adoptive immunotherapy against renal cell carcinoma (RCC) in a...
Transforming growth factor-beta (TGF-beta) is a potent immunosuppressant. Overproduction of TGF-beta...
BACKGROUND. TGF-beta is a potent immunosuppressant. High levels of TGF-beta produced by cancer cells...
Dendritic cells (DCs) have been widely used as cancer vaccines. However, their functional abilities ...
BACKGROUND: One bottleneck for adoptive T cell therapy (ACT) is recruitment of T cells into tumors. ...
<p>The minimal tumorigenic dose was given to FVB/N mice on day 0; Cy was given on day 2; vaccine or ...
Adoptive T cell transfer therapy, the ex vivo activation, expansion, and subsequent administration o...
Adoptive immunotherapy (AIT) involving transfer of tumor-sensitized T lymphocytes in combination wit...
Because CD4(+) T cells play a key role in aiding cellular immune responses, we wanted to assess whet...
BACKGROUND & AIMS: Pancreatic adenocarcinoma (PAC) is often diagnosed at an advanced and inoperable ...
Adoptive T-cell therapy is a cancer treatment strategy where T cells from a cancer patient are harve...
With the establishment of clinically effective adoptive T-cell therapy for metastatic cancer, effort...
Activated T cells expressing endogenous or transduced TCRs are two cell types currently used in clin...
Transforming growth factor beta (TGF-beta) is a potent immunosuppressant. The present study was cond...
Purpose: Transforming growth factor-beta (TGF-beta) is a potent immunosuppressor that has been assoc...
In order to test the effectiveness of adoptive immunotherapy against renal cell carcinoma (RCC) in a...
Transforming growth factor-beta (TGF-beta) is a potent immunosuppressant. Overproduction of TGF-beta...
BACKGROUND. TGF-beta is a potent immunosuppressant. High levels of TGF-beta produced by cancer cells...
Dendritic cells (DCs) have been widely used as cancer vaccines. However, their functional abilities ...
BACKGROUND: One bottleneck for adoptive T cell therapy (ACT) is recruitment of T cells into tumors. ...
<p>The minimal tumorigenic dose was given to FVB/N mice on day 0; Cy was given on day 2; vaccine or ...
Adoptive T cell transfer therapy, the ex vivo activation, expansion, and subsequent administration o...
Adoptive immunotherapy (AIT) involving transfer of tumor-sensitized T lymphocytes in combination wit...
Because CD4(+) T cells play a key role in aiding cellular immune responses, we wanted to assess whet...
BACKGROUND & AIMS: Pancreatic adenocarcinoma (PAC) is often diagnosed at an advanced and inoperable ...
Adoptive T-cell therapy is a cancer treatment strategy where T cells from a cancer patient are harve...
With the establishment of clinically effective adoptive T-cell therapy for metastatic cancer, effort...
Activated T cells expressing endogenous or transduced TCRs are two cell types currently used in clin...